CRPS-Hand: Contrast + Compression vs Whirlpool
Combined Contrast Therapy and Intermittent Compression vs Whirlpool Therapy in Post-Traumatic Hand and Wrist CRPS: A Randomized Controlled Trial
調査の概要
状態
詳細な説明
Complex Regional Pain Syndrome Type 1 (CRPS-I) is a condition that may develop after upper extremity trauma, surgical interventions, or central nervous system disorders, leading to chronic pain and functional impairment. Hydrotherapy modalities such as whirlpool and contrast bath therapy are commonly used; however, comparative evidence with combined thermal and compression-based systems remains limited.
Combined contrast therapy with intermittent compression is a non-invasive intervention delivered using the Game Ready MED4 Elite device, which integrates thermal therapy (cold-warm) with intermittent pneumatic compression (IPC). Evidence, particularly from postoperative orthopedic settings, suggests that this approach may reduce pain and edema and promote functional recovery. Cryotherapy reduces inflammation and vascular permeability, thermotherapy promotes vasodilation and tissue relaxation, and intermittent pneumatic compression (IPC) enhances venous and lymphatic return, supporting regional circulation.
The whirlpool method is a commonly used adjunctive physical therapy modality in CRPS-I treatment, involving immersion of the affected extremity in circulating water at 38-40°C. This technique provides both thermal and mechanical stimulation, promoting regional circulation, reducing muscle spasm, and facilitating edema drainage. Additionally, the gentle massaging effect of water turbulence may contribute to pain modulation and tissue relaxation.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Gizem Suna Tuncer, MD, Specialist Physician
- 電話番号：+905347953185
- メール：sunagizem05@gmail.com
研究場所
-
-
Yenimahalle
-
Ankara、Yenimahalle、トルコ（Türkiye）、06370
- 募集
- Etlik City Hospital, Department of Physical Medicine and Rehabilitation
-
コンタクト：
- Gizem Suna Tuncer, M.D
- 電話番号：+905347953185
- メール：sunagizem05@gmail.com
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Patients diagnosed with Complex Regional Pain Syndrome Type 1 (CRPS-I) according to the Budapest Criteria
- Age between 18 and 80 years
- CRPS developed following upper extremity trauma (e.g., hand or wrist fracture, soft tissue injury)
- Symptom duration less than 3 months (subacute stage)
- Ability and willingness to provide written informed consent and voluntarily participate in the study
Exclusion Criteria:
- Patients diagnosed with Complex Regional Pain Syndrome Type 2 (CRPS-II) or with evidence of peripheral nerve injury
- History of peripheral neuropathy, Raynaud's phenomenon, or vascular circulation disorders
- Presence of impaired skin integrity, open wounds, infection, or dermatological disease in the affected area
- History of cold or heat intolerance, cold urticaria, or hypersensitivity to thermal modalities
- Active infection or severe edema in the affected extremity
- Presence of serious systemic diseases (cardiovascular, pulmonary, renal, or neurological)
- Receipt of similar physical therapy or modality-based treatment within the past 3 months
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Combined Contrast Therapy with Intermittent Compression
Participants in this group will receive combined contrast therapy with intermittent pneumatic compression in addition to a standardized exercise program.
The intervention will be delivered over a 3-week period (5 sessions/week, 15 sessions in total).
Combined contrast therapy will integrate alternating hot and cold thermal therapy with intermittent pneumatic compression.
The standardized exercise program will include supervised range-of-motion, stretching, and upper extremity mobility exercises targeting the wrist and hand.
|
This non-invasive intervention will be delivered using the Game Ready MED4 Elite device, which integrates thermal therapy (hot-cold) with intermittent pneumatic compression (IPC). The device is capable of simultaneously providing contrast therapy and intermittent pneumatic compression and is widely used in upper and lower extremity rehabilitation. Rapid Contrast Therapy Protocol: Heat application: Applied at 39 °C for 3 minutes Cold application: Applied at 15 °C for 1 minute, with mild compression during the cold phase Cycle duration: The heat-cold cycle will be repeated continuously for a total of 15 minutes
他の名前：
|
|
アクティブコンパレータ：Whirlpool Therapy
Participants in this group will receive whirlpool therapy along with a standardized exercise program. The intervention will be administered over a 3-week period, 5 sessions per week, for a total of 15 sessions. Whirlpool therapy will be applied by immersing the affected hand and wrist in circulating water maintained at 40 °C, providing both thermal and mechanical stimulation. The standardized exercise program will include supervised range-of-motion, stretching, and upper extremity mobility exercises targeting the wrist and hand. |
Whirlpool therapy is a hydrotherapy modality used to enhance circulation in the upper extremity, reduce muscle spasm, alleviate pain, and facilitate edema resolution. In this study, a Technomex® whirlpool device will be used for hydrotherapy applications. The water temperature will be set at 40 °C and continuously monitored with a thermometer. The device motor will generate a circular turbulent water flow. The patient's hand and wrist will be positioned comfortably in the tank without compromising circulation. The duration of each session will be 15 minutes.
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Visual Analog Scale (VAS)
時間枠：At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up).
|
Patients rate their pain on a 0-10 scale.
A lower score indicates reduced pain.
|
At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up).
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Hand Function (QuickDASH)
時間枠：At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up).
|
The Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire is a brief and practical tool used to assess upper extremity functional status and its impact on daily activities.
It is the short form of the original DASH questionnaire and consists of 11 items.
Participants rate their difficulty in performing daily activities involving the arm, shoulder, and hand using a 5-point Likert scale.
Scores are standardized on a 0-100 scale, where 0 indicates no disability and 100 indicates the highest level of disability.
|
At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up).
|
|
Neuropathic Pain Assessment (LANSS)
時間枠：at baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
Neuropathic pain will be evaluated using the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale.
This tool assesses pain characteristics and sensory dysfunction through a combination of patient-reported symptoms and clinical examination findings.
The total score ranges from 0 to 24, with scores ≥12 suggesting the presence of neuropathic pain.
|
at baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
|
Edema Measurement (Circumferential Measurement)
時間枠：at baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
Edema will be assessed using circumferential measurements with a measuring tape at the wrist and palm.
Wrist circumference will be measured just proximal to the distal radioulnar joint, and palm circumference will be measured at the widest level across the metacarpal heads.
Measurements will be performed with the patient in a relaxed sitting or standing position, with the hand and wrist in a neutral position and the limb supported to avoid muscle contraction.
The tape will be applied gently without compression.
Two to three measurements will be taken at each site, and the average value will be recorded.
|
at baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
|
Range of Motion (ROM) and Finger-to-Palm Crease Distance (FT-PCD)
時間枠：At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
Wrist range of motion will be assessed by measuring wrist flexion and extension using a standard hand goniometer.
The patient will be positioned in sitting with the shoulder in neutral position, the elbow at 90° flexion, the forearm in neutral rotation, and the wrist in a neutral position.
Each movement will be measured 2-3 times, and the average value will be recorded.
|
At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
|
Hand Grip Strength (HGS)
時間枠：at baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
Hand grip strength will be measured using a Jamar hand dynamometer (Jamar, USA) in accordance with the standardized position recommended by the American Society of Hand Therapists.
Participants will be seated with the shoulder in adduction and neutral rotation, the elbow at 90° flexion, the forearm in neutral position, and the wrist in a neutral position.
Three measurements will be performed for each participant with a 1-minute rest interval between trials, and the average value will be recorded.
Grip strength will be expressed in kilograms-force (kgf).
|
at baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
|
Finger-to-Palm Crease Distance (FT-PCD)
時間枠：At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
Finger-to-palm crease distance (FT-PCD) will be measured in centimeters as the distance between the tip of the third finger and the distal palmar crease.
This measurement will be used to quantitatively assess limitations in finger flexion associated with edema and joint stiffness.
|
At baseline, at 3 weeks (end of treatment), and at 7 weeks (follow-up)
|
協力者と研究者
捜査官
- 主任研究者：Gizem Suna Tuncer, MD, Specialist Physician、Ankara Etlik City Hospital
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- AESH-EK-2026-063
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。